Eli Lilly’s blockbuster antidepressant Cymbalta can now also be marketed as a treatment for chronic musculoskeletal pain, such as osteoarthritis and lower back pain, following FDA approval yesterday.
Continue r…
Shares of pharmaceutical companies Amylin, Alkermes, and Eli Lilly — partners in a new diabetes drug Bydureon — have tanked in morning trading as the U.S. Food and Drug Administration declined on Tuesday to approve the drug w…
A U.S. Food and Drug Administration advisory panel voted on Thursday in favor of expanding Alkermes’ alcohol addiction treatment drug, Vivitrol, to treat opioid addiction.
Continue reading Alkermes Opioid Addic…
It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
…